hers - Search News

Hims & Hers to offer at-home blood draws and lab testing

Hosted on MSN · 1d

Hims & Hers to offer at-home blood draws, lean into 'peptide innovations' with new acquisitions

The startup is expanding its services less than one year after it started offering compounded GLP-1 weight loss drugs.

Investopedia on MSN · 3d

Hims & Hers Stock Hits Record High on Blood-Testing Lab Acquisition

Hims & Hers Health shares jumped some 20% to a record high on Wednesday following the announcement that it acquired lab testing facility Trybe Labs.

Bloomberg on MSN · 3d

Hims & Hers Buys Lab to Expand Into At-Home Blood Testing

Hims & Hers Health Inc. is expanding beyond its successful foray into providing copycat weight-loss drugs with the acquisition of a home blood-testing company.

Hims & Hers Stock Plummets. Wegovy Shortage Is Over.

Investopedia on MSN · 1d

Hims & Hers Stock Drops as FDA Says Ozempic and Wegovy No Longer in Short Supply

Shares of Hims & Hers Health plunged Friday after the Food & Drug Administration said a shortage of the active ingredient in Eli Lilly’s Wegovy and Novo Nordisk’s Ozempic has been resolved.

Barron's on MSN · 1d

Hims & Hers Stock Plummets. The Wegovy Shortage Is Over.

The telehealth company has been selling a copycat version of a popular obesity drug during the recent shortage.

The Motley Fool · 1d

Why Hims & Hers Health Stock Is Plummeting Today

Hims & Hers will no longer be able to sell generic "compounded" versions, a key driver of its recent success. The U.S. Food and Drug Administration (FDA) removed semaglutide injection products like the blockbuster drugs Ozempic and Wegovy from its shortage list.

Hims, Hers Health

The Motley Fool on MSN · 2d

Why Hims & Hers Stock Dropped Today

Raising its price target on the shares to $21, reports The Fly, BofA nonetheless reiterated an "underperform" ( i.e., sell) rating on Hims & Hers stock. Investors are taking the hint, and doing just that.

AOL · 1d

What's Going On With Hims & Hers Health Stock Today?

Hims & Hers Health, Inc. (NYSE:HIMS) announced the acquisition of a California-based peptide facility to enhance its domestic supply chain and meet rising demand for personalized medications. The deal’s terms were not disclosed.

StockStory.org on MSN · 1d

Why Hims & Hers Health (HIMS) Shares Are Getting Obliterated Today

What Happened? Shares of telehealth company Hims & Hers Health (NYSE:HIMS) fell 24% in the afternoon session after U.S. Food and Drug Administration (FDA) reported that the shortage of weight-loss drugs such as Wegovy and Ozempic has ended.

Hims & Hers Health (HIMS) Upward Trajectory Boosted by Recent Acquisition

Telehealth pioneer Hims & Hers Health (HIMS) stock is soaring, with a 12% gain in recent days and a whopping 176% in the last ...

22hon MSN

These Stocks Moved the Most Today: UnitedHealth, Alibaba, Rivian, Celsius, Booking, Block, Akamai, Hims & Hers, and More

UnitedHealth declines following a report that the Justice Department has been investigating the company’s Medicare billing ...

Hims & Hers Health: The Ultimate Pick For The Next Decade

Hims & Hers Health, Inc. is a dramatically undervalued company if your holding period can be measured in decades. Read more ...

Novo Nordisk up 6%, Hims & Hers down 15% as FDA says Ozempic shortage over

Shares of Novo Nordisk (NVO) are up 6% in pre-market trading after a FDA drug shortage notice indicated that a shortage of several versions of ...

Money Morning3d

Is Hims & Hers In the Midst of a Short Squeeze?

What Hims & Hers stock could be witnessing now is a short-squeeze. As its stock began rising sharply, short-sellers move to get out. So over the past week, we’ve seen shares surge 60%. In midday ...

Hims & Hers Q4 Preview: Is The Super Bowl Ad Worth $5B In Market Cap? (Rating Downgrade)

Investors could be overestimating the contribution of Hims & Hers' compounded GLP-1 medications to its top line. Read why I ...

Hims & Hers price target raised to $21 from $18 at BofA

BofA raised the firm’s price target on Hims & Hers to $21 from $18 and keeps an Underperform rating on the shares. The firm increased Q4 ...

4don MSN

A woman gave birth to a baby via IVF then realized it wasn't hers. 5 months later, she lost custody.

A woman is suing a fertility clinic for transferring another couple's embryo into her uterus. They realized the error when ...

Some results have been hidden because they may be inaccessible to you

Show inaccessible results

Hims & Hers to offer at-home blood draws and lab testing

Hims & Hers Stock Plummets. Wegovy Shortage Is Over.

Hims, Hers Health

Related topics